> top > projects > semrep-sample > docs > PubMed:10064103 > annotations
semrep-sample Home  

PubMed:10064103 JSONTXT 12 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
E1-ti-1 0-34 cui:C1321301 denotes Peripheral blood mononuclear cells
E2-ti-1 49-57 cui:C0030705 denotes patients
T1 58-62 PROCESS_OF denotes with
E3-ti-1 63-83 cui:C0011881 denotes diabetic nephropathy
E4-ti-1 89-98 cui:C0205217 denotes increased
E5-ti-1 117-133 cui:C0242606 denotes oxidative-stress
E6-ti-1 134-143 cui:C0332324 denotes sensitive
E7-ti-1 144-164 cui:C0040648 denotes transcription factor
E8-ti-1 165-174 cui:C0079904 denotes NF-kappaB
E1-ab-1 176-185 cui:C0205217 denotes Increased
E2-ab-1 186-202 cui:C0242606 denotes oxidative stress
E3-ab-1 207-217 cui:C0750530 denotes subsequent
E4-ab-1 236-256 cui:C0040648 denotes transcription factor
E5-ab-1 257-266 cui:C0079904 denotes NF-kappaB
E6-ab-1 290-301 cui:C1527148 denotes development
E7-ab-1 305-309 cui:C0205087 denotes late
E8-ab-1 310-332 cui:C0271672 denotes diabetic complications
E1-ab-2 355-371 cui:C0242606 denotes oxidative stress
E2-ab-2 382-391 cui:C0079904 denotes NF-kappaB
E3-ab-2 417-425 cui:C0030705 denotes patients
T2 426-430 PROCESS_OF denotes with
E4-ab-2 431-451 cui:C0011881 denotes diabetic nephropathy
E5-ab-2 463-499 cui:C0949632 denotes Electrophoretic Mobility Shift Assay
E6-ab-2 506-522 cui:C0522525 denotes semiquantitative
E7-ab-2 523-532 cui:C1511790 denotes detection
E8-ab-2 533-539 cui:C0449913 denotes system
E9-ab-2 570-579 cui:C0079904 denotes NF-kappaB
E10-ab-2 611-645 cui:C1321301 denotes peripheral blood mononuclear cells
E1-ab-3 662-670 cui:C0030705 denotes patients
T3 671-675 PROCESS_OF denotes with
E2-ab-3 676-693 cui:C0011849 denotes diabetes mellitus
E3-ab-3 695-699 cui:C1547052 denotes Type
E4-ab-3 706-713 cui:C0441730 denotes Type II
E1-ab-4 716-724 cui:C0030705 denotes Patients
T4 725-729 PROCESS_OF denotes with
E2-ab-4 730-750 cui:C0011881 denotes diabetic nephropathy
E3-ab-4 758-764 cui:C0205250 denotes higher
E4-ab-4 765-774 cui:C0079904 denotes NF-kappaB
E5-ab-4 783-791 cui:C0439167 denotes activity
E6-ab-4 795-832 cui:C0949632 denotes Electrophoretic Mobility Shift Assays
E7-ab-4 837-845 cui:C0442821 denotes stronger
E8-ab-4 878-887 cui:C1515877 denotes activated
E9-ab-4 906-914 cui:C0030705 denotes patients
E10-ab-4 923-928 cui:C0022646 denotes renal
T5 923-942 LOCATION_OF denotes renal complications
E11-ab-4 929-942 cui:C0009566 denotes complications
E1-ab-5 944-953 cui:C0079904 denotes NF-kappaB
E2-ab-5 962-970 cui:C0439167 denotes activity
E3-ab-5 1001-1012 cui:C0001925 denotes albuminuria
E4-ab-5 1034-1048 cui:C0145779 denotes thrombomodulin
E5-ab-5 1049-1070 cui:C0683150 denotes plasma concentrations
E6-ab-5 1098-1109 cui:C0001925 denotes albuminuria
T6 1110-1120 ASSOCIATED_WITH denotes associated
E7-ab-5 1121-1144 cui:C0856169 denotes endothelial dysfunction
E1-ab-6 1151-1156 cui:C1442459 denotes 3 day
E2-ab-6 1157-1175 cui:C0021810 denotes intervention study
E3-ab-6 1199-1210 cui:C0003402 denotes antioxidant
T7 1199-1224 ISA denotes antioxidant thioctic acid
E4-ab-6 1211-1224 cui:C0023791 denotes thioctic acid
E5-ab-6 1226-1243 cui:C0023791 denotes alpha-lipoic acid
E6-ab-6 1249-1252 cui:C0439228 denotes day
E7-ab-6 1267-1271 cui:C0205455 denotes nine
E8-ab-6 1272-1280 cui:C0030705 denotes patients
T8 1281-1285 PROCESS_OF denotes with
E9-ab-6 1286-1306 cui:C0011881 denotes diabetic nephropathy
E10-ab-6 1307-1323 cui:C0242606 denotes oxidative stress
E11-ab-6 1327-1341 cui:C0444263 denotes plasma samples
E12-ab-6 1367-1376 cui:C0214222 denotes NF-kappaB
E13-ab-6 1385-1393 cui:C0439167 denotes activity
E14-ab-6 1414-1448 cui:C1321301 denotes peripheral blood mononuclear cells
E1-ab-7 1490-1510 cui:C0040648 denotes transcription factor
E2-ab-7 1511-1520 cui:C0079904 denotes NF-kappaB
E3-ab-7 1541-1575 cui:C1321301 denotes peripheral blood mononuclear cells
T9 1576-1578 PART_OF denotes of
E4-ab-7 1579-1587 cui:C0030705 denotes patients
T10 1588-1592 PROCESS_OF denotes with
E5-ab-7 1593-1610 cui:C0011849 denotes diabetes mellitus
E6-ab-7 1641-1661 cui:C0011881 denotes diabetic nephropathy
E1-ab-8 1663-1672 cui:C0214222 denotes NF-kappaB
T11 1673-1683 STIMULATES denotes activation
E2-ab-8 1699-1703 cui:C0449719 denotes part
E3-ab-8 1717-1733 cui:C0242606 denotes oxidative stress
E4-ab-8 1740-1753 cui:C0023791 denotes thioctic acid
E5-ab-8 1755-1772 cui:C0023791 denotes alpha-lipoic acid
E6-ab-8 1774-1781 cui:C0392756 denotes reduced
E7-ab-8 1782-1791 cui:C0214222 denotes NF-kappaB
E8-ab-8 1800-1808 cui:C0439167 denotes activity
R1 E3-ti-1 T1 subjectOf diabetic nephropathy,with
R10 E11-ab-4 T5 objectOf complications,renal complications
R11 E4-ab-5 T6 subjectOf thrombomodulin,associated
R12 E7-ab-5 T6 objectOf endothelial dysfunction,associated
R13 E4-ab-6 T7 subjectOf thioctic acid,antioxidant thioctic acid
R14 E3-ab-6 T7 objectOf antioxidant,antioxidant thioctic acid
R15 E10-ab-6 T8 subjectOf oxidative stress,with
R16 E8-ab-6 T8 objectOf patients,with
R17 E3-ab-7 T9 subjectOf peripheral blood mononuclear cells,of
R18 E4-ab-7 T9 objectOf patients,of
R19 E5-ab-7 T10 subjectOf diabetes mellitus,with
R2 E2-ti-1 T1 objectOf patients,with
R20 E4-ab-7 T10 objectOf patients,with
R21 E4-ab-8 T11 subjectOf thioctic acid,activation
R22 E1-ab-8 T11 objectOf NF-kappaB,activation
R3 E4-ab-2 T2 subjectOf diabetic nephropathy,with
R4 E3-ab-2 T2 objectOf patients,with
R5 E2-ab-3 T3 subjectOf diabetes mellitus,with
R6 E1-ab-3 T3 objectOf patients,with
R7 E2-ab-4 T4 subjectOf diabetic nephropathy,with
R8 E1-ab-4 T4 objectOf Patients,with
R9 E10-ab-4 T5 subjectOf renal,renal complications